HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aortic valve disease in Marfan syndrome.

Abstract
The Marfan syndrome patient undergoes care by many different physicians for the treatment of the varied systems affected by this connective tissue disorder. The most frequent visits are to a cardiologist, with referral to a cardiovascular surgeon who attends to the problems of dilatation and dissection of the ascending aorta. Follow-up is lifelong. Although currently some surgeons prefer to resuspend rather than replace the aortic valve, composite valve graft replacement for aortic root dilatation and aortic valve insufficiency has steadily improved patient outcome. At the same time, the almost daily discoveries of genetic science show great promise in eliminating connective tissue disorders such as Marfan syndrome in the not-too-distant future.
AuthorsH J Safi, A Vinnerkvist, J K Bhama, C C Miller 3rd, S Koussayer, A Haverich
JournalCurrent opinion in cardiology (Curr Opin Cardiol) Vol. 13 Issue 2 Pg. 91-5 (Mar 1998) ISSN: 0268-4705 [Print] United States
PMID9593547 (Publication Type: Journal Article, Review)
Topics
  • Aortic Valve
  • Cardiovascular Surgical Procedures (methods)
  • Heart Valve Diseases (etiology)
  • Humans
  • Marfan Syndrome (complications, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: